Clinical Pharmacology Services at Quotient Sciences

Looking for a clinical pharmacology partner?

We have over 30 years of experience in integrated first-in-human and clinical pharmacology.

Get in touch

We can accelerate your molecule from FIH to POC

When looking for a partner who is dedicated to Phase I trials and early development, trust Quotient Sciences. We accelerate your molecule from first-in-human (FIH) to proof of concept (POC), helping you make critical decisions earlier.

Seamless delivery

Seamless delivery

We are dedicated to seamlessly deliver your studies with the highest quality of service and speed.
Meeting milestones

Meeting milestones

As experts in clinical pharmacology, we shorten timelines by cutting through silos, so your project can be a success.
Reducing risks

Reducing risks

We have years of experience in First-in-Human trials, always focussing on participant safety and risk management.

Leverage the expertise of Quotient Sciences, to benefit your business

Dedicated to your Phase I study

Globally, we have completed more than 1,300 Phase I studies at our facilities.

Purpose-built Phase I units in the US and UK
229 beds globally
Experienced team of 16 physicians and principal investigators
Database of more than 25,000 healthy volunteers
UK Medicines and Healthcare Products Regulatory Agency (MHRA), and US Food and Drug Administration (FDA) inspected facilities
Industry-leading US Institutional Review Board (IRB) and UK Clinical Trial Authorization (CTA) approval timelines

Fully integrated programs

We have the experience and expertise to seamlessly deliver your studies with the highest quality service and speed. If you do need a fully integrated solution, including data management, data analysis, statistics, and medical writing, we can help your program.

Experts in FIH studies

We have a proven track record spanning more than 30 years. Our clinical pharmacology expertise includes:

FIH (SAD/MAD), DDI, food effect, and ADME experience
Experienced project managers guiding on-time delivery, within budget and to the highest quality
On-site pharmacy compounding and integrated real-time, adaptive Good Manufacturing Practice (GMP) manufacturing
Formulation development for all dosage forms
Early-phase data sciences group providing a full-service
Regulatory support to ensure a seamless FDA or MHRA submission and approval process

Achieve your drug program’s goals with one, integrated partner

Translational Pharmaceutics®

Integrated development platform that is proven to reduce timelines by >12 months.
Clinical Manufacturing

Clinical trial supplies for oral, injectable and inhaled dosage forms.
Clinical Pharmacology

Phase I healthy volunteer studies & 14C Human ADME.
Commercial Manufacturing

Tech transfer, Process Scale-Up & Optimization, Lifecycle Management.
Drug Substance

PR&D, Custom Synthesis and drug substance characterization.
Formulation Development

Simple & complex dosage forms: PIB, PIC, Tablets, Poorly Soluble, Modified-Release, Pediatrics.
Bioanalysis

Rapid bioanalytical data in discovery, pre-clinical & clinical.
Data Sciences

Rapid access to clinical data & results to accelerate drug development.
Consulting

Holistic scientific advice at each stage of drug development.

Customer success

Customer Testiomonials at Quotient Sciences

“The combination of GMP manufacturing and clinical testing within one organization was, as far as we are aware, entirely unique... The understanding we have gained through working with Quotient Sciences in terms of both the formulation development and the manufacturing will be invaluable.”

Dr David Hava, Chief Scientific Officer at Pulmatrix

Read case study

“The company’s ability to integrate manufacturing and dosing really accelerated the conduct of the study and was one of the main reasons that Corcept Therapeutics selected Quotient Sciences to undertake the study.”

Hazel Hunt, Chief Scientific Officer at Corcept Therapeutics

Read case study

“Quotient Sciences’ real-time manufacturing capabilities were a key factor in determining the speed at which this study could be concluded, offering the rare combination or GMP manufacturing and clinical administration on the same site, even for complex formulations and dosage forms. This allowed us to progress much faster.”

Dr Phil Collis, Vice President of Development at BioCryst Pharmaceuticals

Read case study

“My first response was this is too good to be true, they can’t do that. We’ve been looking for this type of solution for years – it can’t be done. However, we made a site visit and, within three days, accepted the proposal... We had clinical data within weeks... reducing the overall timeline by half, if not more.”

Deborah Gouveia, Vice President, Program & Alliance Management at Stealth BioTherapeutics

Read case study

“Quotient Sciences is an honest and straight-forward company with a very progressive attitude... What makes them unique is the way in which the pharmaceutical products are made on site and transferred, without leaving the building, to the clinical unit and a good, large and reliable pool of healthy volunteers.”

Gillian C. Ivers-Read, Former Executive VP & Chief Regulatory Officer of Clovis Oncology

Read case study

Who are Quotient Sciences?

More than a CDMO:CRO.

Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

About us Global customers FAQs Resources